Table 3.
Associations of patient-reported or clinician-reported symptoms and performance status with risk of death or risk of ER admission (n = 163)*
| Threshold | Reporter | Risk of death |
Risk of ER admission |
% Reaching threshold before death | % Dying who reached threshold | ||
| HR (95% CI) | P | HR (95% CI) | P | ||||
| Fatigue | |||||||
| Moderate | Patient | 1.46 (0.79 to 2.69) | .23 | 1.18 (0.75 to 1.83) | .48 | 71 | 46 |
| Clinician | 2.75 (1.54 to 4.91) | <.001 | 1.87 (1.23 to 2.86) | .004 | 66 | 48 | |
| Severe | Patient | 1.44 (0.89 to 2.37) | .15 | † | † | 37 | 48 |
| Clinician | 2.39 (1.43 to 4.46) | .003 | † | † | 17 | 57 | |
| Nausea† | |||||||
| Moderate | Patient | 1.27 (0.74 to 2.18) | .38 | † | † | 33 | 45 |
| Clinician | 2.07 (1.18 to 3.63) | .01 | † | † | 16 | 65 | |
| Constipation† | |||||||
| Moderate | Patient | 1.26 (0.74 to 2.13) | .40 | 1.53 (0.95 to 2.45) | .08 | 28 | 47 |
| Clinician | 1.68 (1.03 to 2.75) | .038 | 1.28 (0.82 to 2.00) | .28 | 39 | 48 | |
| KPS | |||||||
| Score ≤80 | Patient | 1.48 (0.92 to 2.51) | .13 | 1.27 (0.84 to 1.910) | .26 | 55 | 46 |
| Clinician | 4.91 (2.89 to 8.38) | <.001 | 1.68 (1.07 to 2.62) | .02 | 48 | 59 | |
| Score ≤70 | Patient | 1.40 (0.84 to 2.35) | .20 | † | † | 28 | 48 |
| Clinician | 6.39 (3.88 to 11.08) | <.001 | † | † | 18 | 77 | |
| Pain | |||||||
| Moderate | Patient | 1.47 (0.89 to 2.41) | .13 | 1.44 (0.95 to 2.180) | .09 | 50 | 47 |
| Clinician | 1.56 (0.94 to 2.59) | .08 | 1.84 (1.22 to 2.76) | .004 | 47 | 51 | |
| Severe | Patient | 2.18 (1.22 to 3.89) | .008 | 1.71 (0.97 to 2.99) | .06 | 24 | 56 |
| Clinician | 2.29 (1.39 to 3.78) | .001 | 1.67 (1.05 to 2.68) | .03 | 29 | 61 | |
CI = confidence interval; ER = emergency room; HR = hazard ratio; KPS = Karnofsky Performance Status. P values (two-sided) were generated by using the two-sided Wald test for parameter estimates.
Too few deaths among patients reaching severe nausea or constipation thresholds, and too few ER admissions among patients reaching severe fatigue, moderate or severe nausea, severe constipation, or KPS 70 or less thresholds to conduct analyses.